Labcorp Holdings Inc. (LH): Cost of Revenue

Annual figures by period end, from SEC filings.

Restated years: each year's figure is from the latest filing that reports it. The company later restated the years ended 2016-12-31, 2021-12-31 (for example after a spin-off or a discontinued operation), while the year before each was last reported on the old basis. Changes across those points are marked n/c (not comparable), and growth rates are not computed across them.

$9.94B
Year ended 2025-12-31
$10.20B
Trailing 12 months to 2026-06-30
+6.8%
3-year compound annual growth
2007-12-31: $2.38B2008-12-31: $2.63B2009-12-31: $2.72B2010-12-31: $2.91B2011-12-31: $3.27B2012-12-31: $3.42B2013-12-31: $3.59B2014-12-31: $3.81B2015-12-31: $5.78B2016-12-31: $6.70B2017-12-31: $7.22B2018-12-31: $8.16B2019-12-31: $8.30B2020-12-31: $9.03B2021-12-31: $8.14B2022-12-31: $8.15B2023-12-31: $8.80B2024-12-31: $9.38B2025-12-31: $9.94B$9.94B
2007-12-31 Cost of Revenue (USD) 2025-12-31
Period endedCost of RevenueChange YoYSource filing
2025-12-31$9.94B+5.9%2026-02-24, From 2025-01-01
2024-12-31$9.38B+6.7%2026-02-24, From 2024-01-01
2023-12-31$8.80B+7.9%2026-02-24, From 2023-01-01
2022-12-31$8.15B+0.1%2025-02-25, From 2022-01-01
2021-12-31$8.14Bn/c2024-02-26, From 2021-01-01
2020-12-31$9.03B+8.7%2023-02-28, From 2020-01-01
2019-12-31$8.30B+1.8%2022-02-25, From 2019-01-01
2018-12-31$8.16B+13.0%2021-02-25, From 2018-01-01
2017-12-31$7.22B+7.7%2020-02-28, From 2017-01-01
2016-12-31$6.70Bn/c2019-02-28, From 2016-01-01
2015-12-31$5.78B+51.7%2018-02-27, From 2015-01-01
2014-12-31$3.81B+6.2%2016-03-01, From 2014-01-01
2013-12-31$3.59B+4.8%2016-03-01, From 2013-01-01
2012-12-31$3.42B+4.7%2015-02-26, From 2012-01-01
2011-12-31$3.27B+12.4%2014-02-25, From 2011-01-01
2010-12-31$2.91B+6.7%2013-02-26, From 2010-01-01
2009-12-31$2.72B+3.5%2012-02-24, From 2009-01-01
2008-12-31$2.63B+10.7%2011-03-07, From 2008-01-01
2007-12-31$2.38Bn/a2010-02-24, From 2007-01-01

Cost of Revenue at similar companies

Companies with the same SEC industry code (Services-Medical Laboratories), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCost of RevenueChange YoY
Labcorp Holdings Inc. (LH)2025-12-31$9.94B+5.9%
Quest Diagnostics Inc (DGX)2025-12-31$7.37B+11.2%
Guardant Health, Inc. (GH)2025-12-31$349.01M+20.4%
Castle Biosciences Inc (CSTL)2025-12-31$71.03M+18.0%
Fulgent Genetics, Inc. (FLGT)2025-12-31$191.80M+8.8%
BillionToOne, Inc. (BLLN)2025-12-31$96.65M+34.9%
Personalis, Inc. (PSNL)2025-12-31$53.87M-6.8%
Exagen Inc. (XGN)2025-12-31$27.78M+23.3%
American Shared Hospital Services (AMS)2025-12-31$23.02M+20.2%

Compare LH, DGX, GH, CSTL side by side · Screen every company in Services-Medical Laboratories ↗